Since increased mutations and chromosomal rearrangements are linked with tumor heterogeneity, disease recurrence, and metastasis, we sought to understand the MYBL2-driven programs promoting disease progression in lung adenocarcinoma. Here, MYBL2 is linked to lung adenocarcinoma.